These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

186 related articles for article (PubMed ID: 11715630)

  • 21. Pathophysiology of antipsychotic drug-induced movement disorders.
    Casey DE
    J Clin Psychiatry; 2004; 65 Suppl 9():25-8. PubMed ID: 15189109
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Extrapyramidal effects of antipsychotic drugs].
    Kulisevsky J; Otermin P
    Neurologia; 2003 Jun; 18(5):262-8. PubMed ID: 12768512
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [The development of psychopharmacotherapy].
    Woggon B
    Schweiz Arch Neurol Neurochir Psychiatr; 1979; 125(2):271-85. PubMed ID: 45344
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Preclinical pharmacology of neuroleptics: focus on new generation compounds.
    Richelson E
    J Clin Psychiatry; 1996; 57 Suppl 11():4-11. PubMed ID: 8941166
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Cutaneous adverse reactions to psychotropic drugs: data from a multicenter surveillance program.
    Lange-Asschenfeldt C; Grohmann R; Lange-Asschenfeldt B; Engel RR; Rüther E; Cordes J
    J Clin Psychiatry; 2009 Sep; 70(9):1258-65. PubMed ID: 19538904
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Nonneuroleptic etiologies of extrapyramidal symptoms.
    Blair DT; Dauner A
    Clin Nurse Spec; 1993 Jul; 7(4):225-31. PubMed ID: 8102320
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Atypical neuroleptics in the treatment of early onset schizophrenia.
    Masi G
    Panminerva Med; 1997 Sep; 39(3):215-21. PubMed ID: 9360425
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Long-term effects of JL 13, a potential atypical antipsychotic, on rat dopamine and serotonin receptor subtypes.
    Moran-Gates T; Massari C; Graulich A; Liégeois JF; Tarazi FI
    J Neurosci Res; 2006 Aug; 84(3):675-82. PubMed ID: 16810690
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Atypical antipsychotic-induced metabolic side effects: insights from receptor-binding profiles.
    Nasrallah HA
    Mol Psychiatry; 2008 Jan; 13(1):27-35. PubMed ID: 17848919
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Receptor pharmacology of neuroleptics: relation to clinical effects.
    Richelson E
    J Clin Psychiatry; 1999; 60 Suppl 10():5-14. PubMed ID: 10340682
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Pharmacologic and pharmacokinetic considerations in choosing an antipsychotic.
    Ereshefsky L
    J Clin Psychiatry; 1999; 60 Suppl 10():20-30. PubMed ID: 10340684
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Behavioural effects of chronic haloperidol and risperidone treatment in rats.
    Karl T; Duffy L; O'brien E; Matsumoto I; Dedova I
    Behav Brain Res; 2006 Aug; 171(2):286-94. PubMed ID: 16697060
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [The atypical neuroleptic concept].
    Azorin JM; Dassa D; Jalfre M
    Encephale; 1992 Sep; 18 Spec No 3():453-7. PubMed ID: 1364079
    [TBL] [Abstract][Full Text] [Related]  

  • 34. CYP 2D6 PM phenotype hypothesis of antidepressant extrapyramidal side-effects.
    Vandel P; Bonin B; Vandel S; Sechter D; Bizouard P
    Med Hypotheses; 1996 Dec; 47(6):439-42. PubMed ID: 8961239
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Fluoxetine and extrapyramidal side effects.
    Coulter DM; Pillans PI
    Am J Psychiatry; 1995 Jan; 152(1):122-5. PubMed ID: 7802102
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Extrapyramidal symptoms are serious side-effects of antipsychotic and other drugs.
    Blair DT; Dauner A
    Nurse Pract; 1992 Nov; 17(11):56, 62-4, 67. PubMed ID: 1359485
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Antidepressants and extrapyramidal effects.
    Prescrire Int; 2003 Feb; 12(63):17-8. PubMed ID: 12602380
    [No Abstract]   [Full Text] [Related]  

  • 38. Oral health impacts of medications used to treat mental illness.
    Cockburn N; Pradhan A; Taing MW; Kisely S; Ford PJ
    J Affect Disord; 2017 Dec; 223():184-193. PubMed ID: 28759866
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Discrimination of neuroleptics by means of their interaction with amfonelic acid: an attempt to characterize the test.
    Waldmeier PC; Huber H; Heinrich M; Stoecklin K
    Biochem Pharmacol; 1985 Jan; 34(1):39-44. PubMed ID: 2857083
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Definition, psychopharmacological basis and clinical evaluation of novel/atypical neuroleptics: methodological issues and clinical consequences.
    Möller HJ
    World J Biol Psychiatry; 2000 Apr; 1(2):75-91. PubMed ID: 12607203
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.